Medication prescribing and pregnancy-related risk factors for women with type 2 diabetes of reproductive age within primary care: a cross-sectional investigation for the PREPARED study
Open Access
- 5 March 2025
- journal article
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 13 (2) , e004312
Abstract
Introduction: Women with type 2 diabetes are at risk of commencing pregnancy while using medications that are either not recommended for pregnancy or with known teratogenicity, which may contribute to adverse pregnancy outcomes. In this study, we aimed to characterize pregnancy-related risk factors and medication exposures among women with type 2 diabetes. Research design and methods: Individual health characteristics, sociodemographic information, and prescription data were extracted from the primary care records of women aged 18–45 years with type 2 diabetes in participating general practices in the UK. Prescribed medications were categorized according to suitability for pregnancy: recommended, not recommended, or not recommended but used if clinically indicated. Logistic regression was used to estimate associations between individual characteristics and medications not recommended for pregnancy. Results: Data on 725 women were extracted. Prescribed medications suggested the presence of numerous comorbidities, with diabetes medications (65%, n=471) and statins (20%, n=145) most frequently prescribed. 37% (n=268) of women took ≥3 medications, and a third (n=269) took medications not recommended for pregnancy. Among those not prescribed contraception (89%, n=646), no one met all clinically recommended pre-pregnancy criteria. In multivariable logistic regression analysis, polypharmacy (OR 3.49 95% CI 2.88 to 4.30) and age (OR 1.04 95% CI 1.00 to 1.09) were associated with use of medications not recommended for pregnancy. Conclusions: Women with type 2 diabetes have suboptimal contraceptive provision despite multiple exposures to medications not recommended for pregnancy. Regular assessment of contraceptive use, reproductive intentions, and medication review is urgently needed in primary care settings to minimize pregnancy-related risks.Keywords
Funding Information
- Health and Social Care Delivery Research (NIHR131250)
This publication has 40 references indexed in Scilit:
- Where do women and men in Britain obtain contraception? Findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)BMJ Sexual & Reproductive Health, 2017
- Weight management during pregnancy: a qualitative study of women’s and care providers’ experiences and perspectivesBMC Pregnancy and Childbirth, 2017
- Polypharmacy in multimorbid older adults: protocol for a systematic reviewSystematic Reviews, 2017
- The experiences of prepregnancy care for women with type 2 diabetes mellitus: a meta-synthesisInternational Journal of Women's Health, 2016
- Actual and preferred contraceptive sources among young people: findings from the British National Survey of Sexual Attitudes and LifestylesBMJ Open, 2016
- Trends in the incidence of diabetes, its clinical sequelae, and associated costs in pregnancyDiabetes/Metabolism Research and Reviews, 2015
- Risk of Adverse Pregnancy Outcomes by Prepregnancy Body Mass IndexObstetrics & Gynecology, 2015
- Experiencing maternity care: the care received and perceptions of women from different ethnic groupsBMC Pregnancy and Childbirth, 2013
- Unintended pregnancies in England in 2010: costs to the National Health Service (NHS)Contraception, 2013
- Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based studyBMJ, 2006